Taping versus electrical stimulation after botulinum toxin type A injection for wrist and finger spasticity. A case-control study

Clin Rehabil. 2005 Sep;19(6):621-6. doi: 10.1191/0269215505cr879oa.

Abstract

Objective: To compare results from two approaches used in conjunction with botulinum toxin type A administration in rehabilitation: the application of a taping system and the electrical stimulation of the injected muscles and splinting.

Design: Case-control study.

Setting: Two tertiary care rehabilitation hospitals in Italy.

Subjects: Sixty-five adult subjects affected by spasticity of the wrist and finger flexors.

Interventions: After injection with botulinum toxin type A, the group at hospital A (n=33) was treated with adhesive taping for six days and those at hospital B (n=32) with electrical stimulation and splinting for six days. Spastic hypertonia at the injected muscles was assessed before treatment, one week and one month post injection.

Main measures: Modified Ashworth Scale.

Results: In group A, the mean Modified Ashworth Scale reduction was 2.76 +/- 0.94 for wrist flexors and 2.45 +/- 0.92 for finger flexors; in group B the mean Modified Ashworth Scale reduction was 2.18 +/- 1.11 for wrist flexors and 2.1 +/- 0.98 for finger flexors. The observed difference between the two groups was statistically relevant (p < 0.05).

Conclusions: Patients treated with adhesive taping and botulinum toxin type A achieved a greater reduction in spastic hypertonia as measured with Modified Ashworth Scale, with less time dedicated for the treatment.

Publication types

  • Multicenter Study

MeSH terms

  • Bandages*
  • Botulinum Toxins, Type A / therapeutic use*
  • Case-Control Studies
  • Electric Stimulation Therapy*
  • Fingers / physiopathology
  • Humans
  • Injections, Intramuscular
  • Muscle Spasticity / physiopathology
  • Muscle Spasticity / therapy*
  • Neuromuscular Agents / therapeutic use*
  • Splints
  • Treatment Outcome
  • Wrist / physiopathology

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A